Health
PROMISING CELL THERAPY OFFERS HOPE FOR RELAPSED OR REFRACTORY T-CELL LEUKAEMIA
Fratricide-resistant CD7 CAR-T therapy by NUS proves effective in treating relapsed or refractory T-cell leukaemia SINGAPORE, Oct. 5, 2024 /PRNewswire/ -- A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic le...
2024-10-05 06:00
7176
Cyient DLM Expands Global Footprint with Strategic Acquisition of US-Based EMS Manufacturer
HYDERABAD, India, Oct. 4, 2024 /PRNewswire/ -- Cyient DLM, a leading integrated electronics manufacturing company, announced today its acquisition of Altek Electronics, a prominent EMS (Electronic Manufacturing Services) company based inthe United States. This strategic move marks a significant m...
2024-10-04 21:00
4556
TiumBio Announces First Patient Dosed in Phase 2 Clinical Trial of Oral Immuno-Oncology Drug TU2218
* TU2218 is a potentially first-in-class dual inhibitor targeting transforming growth factor beta receptor 1 (TGFR1) and vascular endothelial growth factor receptor 2 (VEGFR2) * The first patient with head and neck squamous cell carcinoma was dosed in the Phase 2a clinical trial of TU2218 *...
2024-10-04 20:00
1650
Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda
Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities inLatin America at premier Life Sciences event LONDON, Oct. 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, today announced the full agenda ...
2024-10-04 15:00
1792
Sirnaomics Has Been Subscribed for 17,527,696 Subscription Shares, New Capital Injection to Promote Business Growth and Development
HONG KONG, GERMANTOWN, Md., and SUZHOU, China,, Oct. 4, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or " Sirnaomics"; stock code: 2257.HK), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutic...
2024-10-04 13:03
5536
ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors
- MSD will supply KEYTRUDA to be evaluated in combination with ABL Bio's ABL103 in a Phase1b/2 clinical trial SEONGNAM, South Korea, Oct. 4, 2024 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee ), a company specializing in bispecific antibodies, today announced that it has entered into a clinical tria...
2024-10-04 12:40
2360
Xinhua Silk Road: Ex-champ Bruno Hasulyo starts new career to bolster SUP in eastern China metropolis
BEIJING, Oct. 4, 2024 /PRNewswire/ -- Born in Hungary, Bruno Hasulyo is not just a professional athlete but also an adventurer at heart and a visionary entrepreneur. His life journey has been driven by a singular goal -- becoming an iconic figure in the world of stand-up paddling (SUP) and usher...
2024-10-04 12:30
7506
Siriraj Enhances Diagnostic Capabilities, a Crucial Factor for Medical Care
BANGKOK, Oct. 4, 2024 /PRNewswire/ -- Siriraj Hospital excels in maintaining its high standards for every service, including diagnostics through the integration of cutting-edge technology into its medical services, furthering its mission to become a global leader in healthcare. The hospital is fo...
2024-10-04 11:18
2216
Agilent and National University of Singapore Launch Center of Excellence in Cell Metabolism to Improve Population Health
Center will enable targeted and untargeted metabolic profiling for
population-based large-scale cohorts across translational research
SINGAPORE, Oct. 4, 2024 /PRNewswire/ -- Agilent Technologies Inc.
2024-10-04 09:00
2673
First Patient Dosed in Phase II 'CA-NINE' Trial of TLX250-CDx for Detection of Recurrent Kidney Cancer After Surgery
MELBOURNE, Australia, Oct. 4, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II trial exploring the clinical utility of Telix's first-in-class investigational PET[1] agent, TLX250-CDx (89Zr-girentu...
2024-10-04 04:00
2850
IBC launches RadSep, Inc.: Best-in-class, highly selective separations using Molecular Recognition Technology™ (MRT™) for production of critical radioisotopes essential to cancer therapies
* Best-in-class, highly selective separations technology for the radiopharmaceuticals industry * Exhibitor at the European Association of Nuclear Medicine (EANM) Congress in Hamburg, Germany 20-23 October 2024 at Booth S14 (Exhibition Hall 3) * Over 36 years of experience with first generatio...
2024-10-03 22:15
1730
WELLlife COVID-19/Influenza A&B Home Test on Sale for Amazon Prime Day
Standfirst: Welllife, a Flu home test in addition to COVID-19 BOLINGBROOK, Ill., Oct. 3, 2024 /PRNewswire/ -- WELLlife, a leading innovator in medical diagnostic and testing solutions, is increasing accessibility to respiratory illness testing this flu season. The WELLlife COVID-19/Influenza A&B...
2024-10-03 21:00
1174
The Exosome Production Method Patent by Panacell Biotech Registered as Original Technology
SEOUL, South Korea, Oct. 3, 2024 /PRNewswire/ -- Panacell Biotech Co., Ltd. (Panacell Biotech) announced that the patent related to their exosome manufacturing method filed last year was registered as a core technology in the patent registry onAugust 7, 2024, following the Patent Act. Panacell B...
2024-10-03 20:00
1693
Veritas Genetic participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients
* The study, conducted in collaboration with the Department of Biomedicine and Prevention at the University of Rome Tor Vergata and Tor Vergata University Hospital, underscores the relevance of polygenic risk scores (PRS) in risk stratification for patients with a genetic predisposition to brea...
2024-10-03 14:00
1735
CNN's 'Tomorrow Transformed' explores how the future of healthcare is connecting lives
HONG KONG, Oct. 3, 2024 /PRNewswire/ -- Since the dawn of healthcare, technology has been drastically improving medical systems and services to help us live longer and better lives. In this special half-hour episode of'Tomorrow Transformed', connections, partnerships, and collaborations in the wo...
2024-10-03 12:16
2281
Millennium Hotels and Resorts Pledges Solidarity for Breast Cancer Awareness Month
The global hospitality brand announces a collaborative event with breast cancer advocate and survivorJill Alphonso and sound healing expert Michele Chong of The Sirius Sound, alongside pink-themed F&B offerings. SINGAPORE, Oct. 2, 2024 /PRNewswire/ -- Millennium Hotels and Resorts (MHR) announce...
2024-10-03 11:41
2537
A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore
Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Accelerate Talent Development SINGAPORE, Oct. 3, 2024 /PRNewswire/ -- The Agency for Science, Technology and Research (A*STAR),Singapore's lead publ...
2024-10-03 09:00
1924
Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
- Non-exclusive voluntary license agreement enables the manufacture and distribution of lenacapavir for HIV prevention and treatment of heavily treatment-experienced patients with multi drug-resistant HIV HYDERABAD, India, Oct. 2, 2024 /PRNewswire/ -- Hetero, India's leading pharmaceutical comp...
2024-10-02 22:53
2507
South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika
* SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in revenue and infrastructure. * The company aims to double sales of IDT Biologika by 2028 through new business projects and operational efficiency. ...
2024-10-02 20:00
1970
Zepp Regains Compliance with NYSE Minimum Price Continued Listing Criterion
MILPITAS, Calif., Oct. 2, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange ("NYSE") datedOctober 2, 2024 (the "Octobe...
2024-10-02 19:00
4002
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5209
